Stay updated with breaking news from Contract Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
13/12/2023 The Vaccine Group has appointed three high-ranking and well-connected animal health experts to form an advisory board to support scale up of the Company's...
The former Talaris space on the U of L Health Sciences Campus downtown won't be quiet for long.
OKLAHOMA CITY & WILMINGTON, N.C.--(BUSINESS WIRE)--Dec 11, 2023--
RoslinCT to manufacture first-ever US FDA approved CRISPR-based gene therapy CASGEVY™ (exagamglogene autotemcel) RoslinCT to manufacture this grou...
Despite an over 86 percent gain in the stock in 2023 YTD, domestic brokerage house Investec sees pharma firm Orchid Pharma (ORCD) rising another 23 percent in the next 12 months. The brokerage has initiated coverage on the stock with a ‘buy’ call and a target price of ₹800.